Richard S.  Casten net worth and biography

Richard Casten Biography and Net Worth

CFO of Baudax Bio
Prior to joining Baudax, Mr. Casten served as Vice President of Finance, Controller and Treasurer at Lupin Pharmaceuticals, Inc. Previous to Lupin, Mr. Casten served in roles of increasing responsibility at Endo International plc, culminating in his role as Senior Director, Financial Planning and Analysis. Prior to Endo, he served in various financial roles at the Campbell Soup Company. Mr. Casten spent the initial ten years of his career in public accounting, with eight years at Ernst & Young LLP, rising to a Senior Manager, Assurance and Advisory Business Services, and at Fishbein & Company as an Assurance Staff Accountant. He holds a Bachelor of Science in Business and Economics, with a major in Accounting, from Lehigh University and a Master’s in Business Administration from the Johnson School at Cornell University. Mr. Casten is a Certified Public Accountant in both Pennsylvania and California and is a member of American and Pennsylvania Institute of Certified Public Accountants.

What is Richard S. Casten's net worth?

The estimated net worth of Richard S. Casten is at least $81.75 as of May 14th, 2021. Mr. Casten owns 3,750 shares of Baudax Bio stock worth more than $82 as of December 16th. This net worth evaluation does not reflect any other assets that Mr. Casten may own. Learn More about Richard S. Casten's net worth.

How do I contact Richard S. Casten?

The corporate mailing address for Mr. Casten and other Baudax Bio executives is 490 LAPP ROAD, MALVERN PA, 19355. Baudax Bio can also be reached via phone at 484-395-2440 and via email at [email protected]. Learn More on Richard S. Casten's contact information.

Has Richard S. Casten been buying or selling shares of Baudax Bio?

Richard S. Casten has not been actively trading shares of Baudax Bio within the last three months. Most recently, on Friday, August 20th, Richard S. Casten bought 1,250 shares of Baudax Bio stock. The stock was acquired at an average cost of $20.40 per share, with a total value of $25,500.00. Learn More on Richard S. Casten's trading history.

Who are Baudax Bio's active insiders?

Baudax Bio's insider roster includes Arnold Baskies (Director), Richard Casten (CFO), Winston Churchill (Director), and Geraldine Henwood (CEO). Learn More on Baudax Bio's active insiders.

Richard S. Casten Insider Trading History at Baudax Bio

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/20/2021Buy1,250$20.40$25,500.00View SEC Filing Icon  
5/14/2021Buy625$31.60$19,750.003,750View SEC Filing Icon  
See Full Table

Richard S. Casten Buying and Selling Activity at Baudax Bio

This chart shows Richard S Casten's buying and selling at Baudax Bio by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Baudax Bio Company Overview

Baudax Bio logo
Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care related settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with other non-NSAID analgesics. It also develops BX1000, an intermediate-acting neuromuscular blocking agent (NMB) that is in phase II clinical trial; BX2000, an ultra- short acting NMB, which is in phase I clinical trial, as well as a proprietary blockade reversal agent; and BX3000, a NMB reversal agent that is in preclinical studies. Baudax Bio, Inc. was incorporated in 2019 and is based in Malvern, Pennsylvania.
Read More

Today's Range

Now: $0.02
Low: $0.02
High: $0.02

50 Day Range

MA: $0.02
Low: $0.02
High: $0.03

2 Week Range

Now: $0.02
Low: $0.01
High: $3.47

Volume

310,800 shs

Average Volume

281,029 shs

Market Capitalization

$1.14 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.57